Narazaciclib | Interleukin Related interleukin-related.com

Product Name :
Narazaciclib

Search keywords :
Narazaciclib

drugId :
null

Target Vo:
AMP-activated protein kinases

Target Vo Short Name :
AMPK

Moa_Name:
AMP-activated protein kinases inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Temple University

Active Company_Name :
Hanx Biopharmaceutical Co Ltd

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JNK1+JNK3 Antibody
Phospho-Chk1 (Ser296) Antibody
Phospho-HSF1 (Ser303/Ser307) Antibody: Phospho-HSF1 (Ser303/Ser307) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 57 kDa, targeting to Phospho-HSF1 (Ser303/Ser307). It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts